Ditchcarbon
  • Contact
  1. Organizations
  2. 3M Co., Branded Pharmaceutical Business in North & Latin America
Public Profile
Research Pending

This profile hasn't yet passed our validation checks

Submit your email to push it up the queue

We'll prioritize this organization's research and notify you when detailed sustainability data becomes available.

US
updated 22 days ago

3M Co., Branded Pharmaceutical Business in North & Latin America

Company website

3M Company, a global leader in innovation, operates its Branded Pharmaceutical Business primarily in North and Latin America, with its headquarters located in the United States. Founded in 1902, 3M has established a strong presence in the healthcare industry, focusing on developing advanced pharmaceutical solutions that enhance patient care. The Branded Pharmaceutical Business offers a diverse range of products, including prescription medications and specialty pharmaceuticals, distinguished by their commitment to quality and efficacy. 3M's unique approach combines cutting-edge technology with a deep understanding of patient needs, positioning the company as a trusted name in healthcare. With a robust market position, 3M has achieved notable milestones, including significant advancements in drug delivery systems and a strong portfolio of patented products. This dedication to innovation and excellence continues to drive 3M's success in the competitive pharmaceutical landscape.

DitchCarbon Score

How does 3M Co., Branded Pharmaceutical Business in North & Latin America's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

20

Industry Average

Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

0

Industry Benchmark

3M Co., Branded Pharmaceutical Business in North & Latin America's score of 20 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

3M Co., Branded Pharmaceutical Business in North & Latin America's reported carbon emissions

Inherited from Bausch Health Companies Inc.

As of the latest available data, 3M Co., Branded Pharmaceutical Business in North & Latin America does not report specific carbon emissions figures, as there is no emissions data provided. The organisation's climate commitments and reduction initiatives are also not detailed, indicating a lack of publicly available targets or achievements in this area. It is important to note that emissions data and climate initiatives for 3M Co. in this context are cascaded from Bausch Health Companies Inc., with a cascade level of 3. This means that any climate-related commitments or performance metrics would be inherited from Bausch Health, which may have its own set of targets and initiatives. Given the absence of specific emissions data and reduction targets, it is unclear how 3M Co. is addressing its carbon footprint or contributing to climate action within the pharmaceutical sector in North and Latin America. The lack of information highlights a potential area for improvement in transparency regarding environmental impact and sustainability efforts.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20222023
Scope 1
46,686,000
00,000,000
Scope 2
50,513,000
00,000,000
Scope 3
19,260,000
00,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. 3M Co., Branded Pharmaceutical Business in North & Latin America's primary industry is , which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for 3M Co., Branded Pharmaceutical Business in North & Latin America is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

3M Co., Branded Pharmaceutical Business in North & Latin America is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Medigene AG

DE
•
Pharmaceutical Preparation Manufacturing
Updated 26 days ago

Merck And Co

US
•
Pharmaceutical Preparation Manufacturing
Updated about 6 hours ago

Allergan

US
•
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251007.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy